Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial
Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays an error screen stating that the study record is currently unavailable. The HTML skeleton and site chrome remain visible around the error message instead of showing the study details.SummaryDifference18%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new page build. This appears to be a backend/frontend update rather than a modification to the study data.SummaryDifference0.0%

- Check23 days agoChange DetectedThe study's keyword/subject taxonomy updates from Fatty Liver Disease to Steatotic Liver Disease, representing a metadata-level change. This aligns the terminology with current clinical usage without altering study details or patient-facing content.SummaryDifference0.0%

- Check30 days agoChange DetectedGlaxoSmithKline is now listed as sponsor, replacing Boston Pharmaceuticals and GSK Research and Development Limited, and the study's external identifiers and related dates (301182, BOS-580-201) have been updated to reflect the current record.SummaryDifference0.4%

- Check37 days agoChange DetectedThe page revision label was updated to v3.6.3, indicating a new build of the page. This represents a maintenance/version update rather than a content modification.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.6.2 appears, replacing the previous v3.6.0. This indicates a minor platform/template update rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.